Comparison of post-therapeutic sequential 131I whole-body scans in the detection of metastatic thyroid cancer-Reference-Cited by-同舟云学术

Comparison of post-therapeutic sequential 131I whole-body scans in the detection of metastatic thyroid cancer

Published:2020-07 Issue:3 Volume:64 Page:
ISSN:1824-4785
Container-title:The Quarterly Journal of Nuclear Medicine and Molecular Imaging
language:
Short-container-title:Q J Nucl Med Mol Imaging

Author:

Qiu Lin,Tan Hui,Yin Hongyan,Zhou Jun,Cheng Dengfeng,Shi Hongcheng

Publisher

Edizioni Minerva Medica

Subject

Radiology, Nuclear Medicine and imaging

Link

https://www.minervamedica.it/pdf.php?cod=R39Y2020N03A0313

Reference24 articles.

1. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

2. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4];Dietlein M;Nucl Med (Stuttg),2016

3. The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer

4. Are Posttherapy Radioiodine Scans Informative and Do They Influence Subsequent Therapy of Patients with Differentiated Thyroid Cancer?

5. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels;Pacini F;J Nucl Med,1987

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A semiquantitative study of the optimal whole-body imaging time after 131I therapy for differentiated thyroid cancer;Frontiers in Endocrinology;2022-08-25

2. Circular RNA hsa_circ_0000282 contributes to osteosarcoma cell proliferation by regulating miR-192/XIAP axis;BMC Cancer;2020-10-23